National Cannabis Party.
There's is the Republican Party, the Democratic Party, and now the National Cannabis Party. The Electoral Party Built by The People Of Cannabis.
Only a political party is powerful enough to control what a government does, and therefore be effectively responsible for it. Welcome To The House Of Cannabis!
Welcome To The House Of Cannabis
The National Cannabis Party is the official Electoral Party registered with the Federal Elections Commission representing the People Of Cannabis. Organized to challenge the most pressing issues and injustices in effort to aid, and support the registered voter in need and in support of cannabis. We seek to identify pain-points at the community level, and demand a seat at the table in Washington.
NCP: Purpose Built by The People of Cannabis
The National Cannabis Party operates on one premise, and one premise alone. we believe "The Plant Belongs The People". We are the party that represents the community, and the voters within. For the first time ever, industry voter voices have a seat in Washington. We will work together to continue building the House Of Cannabis voter by voter, community by community, issue by issue.
We Are Fighting The Big Fights
US Patent No. 6,630,507 Update: The People Have Spoken!
U.S. Patent 6,630,507 Is Now Expired For Life!
The U.S. government held Patent No. 6,630,507 until 2019, but continued to operate and hide the true status of the patent until 2021/2022. And for obvious reasons, the USPTO did not list the or publicize the new status. Public outcry had great influence on creating awareness as to the injustice and outright hypocrisy of the patent being held. This allowed for The National Cannabis Party (The People's Official House of Cannabis), to publicly announce its campaign challenging the patent as a Electoral Party.
The results are the forcing of the USPTO to publicly update the patent status.
Congratulations to you all!
UP Next - Descheduling The Plant:
With the success of the US Patent update, Descheduling is now in reach!
In the United States, the removal of cannabis from Schedule I of the Controlled Substances Act, the most tightly restricted category reserved for drugs that have "no currently accepted medical use,” has been proposed repeatedly since 1972. Descheduling proponents argue that cannabis does not meet the Controlled Substances Act's strict criteria for placement in Schedule I and so the government is required by law to permit medical use or to remove the drug from federal control altogether. The US government, on the other hand, maintains that cannabis is dangerous enough to merit Schedule I status. The dispute is based on differing views on both how the Act should be interpreted and what kinds of scientific evidence are most relevant to the rescheduling decision.
A US judge says in a DEA concurring opinion that the agency may soon be forced to consider a policy change anyway based on a misinterpretation of the medical value of cannabis (referring to both Former U.S. Patent 6630507, and DEA public information).